相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Jennifer Y. Wo et al.
PRACTICAL RADIATION ONCOLOGY (2021)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
Hyun Kim et al.
CLINICAL COLORECTAL CANCER (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
Total Neoadjuvant Therapy in Rectal Cancer A Systematic Review and Meta-analysis of Treatment Outcomes
Fausto Petrelli et al.
ANNALS OF SURGERY (2020)
Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
Julio Garcia-Aguilar et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Rectal Cancer, Version 6.2020 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial
Maxime J. M. van der Valk et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center
Paul B. Romesser et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer
Moriah E. Wright et al.
DISEASES OF THE COLON & RECTUM (2019)
Long-course preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study
B. Cisel et al.
ANNALS OF ONCOLOGY (2019)
Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer
Shichao Wang et al.
RADIATION ONCOLOGY (2019)
Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial
Johan Erlandsson et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer
Scott K. Sherman et al.
JAMA ONCOLOGY (2019)
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith et al.
JAMA ONCOLOGY (2019)
Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer
Ann C. Raldow et al.
JAMA NETWORK OPEN (2019)
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer-The New Standard of Care?
Theodore S. Hong et al.
JAMA ONCOLOGY (2018)
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek et al.
JAMA ONCOLOGY (2018)
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
Simon Gollins et al.
BRITISH JOURNAL OF CANCER (2018)
Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
Omar Abdel-Rahman et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis
Stephanie Markovina et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer
Naruhiko Ikoma et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
Johan Erlandsson et al.
LANCET ONCOLOGY (2017)
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity
Randa Tao et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
K. Bujko et al.
ANNALS OF ONCOLOGY (2016)
National Trends in Nonoperative Management of Rectal Adenocarcinoma
Clayton Tyler Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial
C. Fernandez-Martos et al.
ANNALS OF ONCOLOGY (2015)
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Julio Garcia-Aguilar et al.
LANCET ONCOLOGY (2015)
Meta-analysis of defunctioning stoma in low anterior resection with total mesorectal excision for rectal cancer: evidence based on thirteen studies
Wen-long Gu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Meta-analysis of elective surgical complications related to defunctioning loop ileostomy compared with loop colostomy after low anterior resection for rectal carcinoma
Hong Zhi Geng et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2015)
Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
Robert J. Myerson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sequential Short Course Radiation and FOLFOX as Preoperative Therapy for Rectal Cancer: Favorable LC, PFS, and QOL at 2 Years
J. R. Olsen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Don Husereau et al.
VALUE IN HEALTH (2013)
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
Samuel Y. Ngan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial
Yu Jo Chua et al.
LANCET ONCOLOGY (2010)
Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
Mark S. Roh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
David Sebag-Montefiore et al.
LANCET (2009)
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer
I Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate
J Folkesson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The modern abdominoperineal excision - The next challenge after total mesorectal excision
R Marr et al.
ANNALS OF SURGERY (2005)
Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: A study of the Dutch colorectal cancer group
M van den Brink et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Analysis of surgical salvage after failure of primary therapy in rectal cancer: Results from Intergroup Study 0114
JE Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
No downstaging after short-term preoperative radiotherapy in rectal cancer patients
CAM Marijnen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
